Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
3.330
+0.010 (0.30%)
At close: Dec 5, 2025, 4:00 PM EST
3.300
-0.030 (-0.90%)
After-hours: Dec 5, 2025, 7:58 PM EST
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $770.75 million as of December 5, 2025. Its market cap has increased by 372.34% in one year.
Market Cap
770.75M
Enterprise Value
793.40M
1-Year Change
372.34%
Ranking
Category
Stock Price
$3.33
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $770.75M, a decrease of -22.56%. That is a compound annual growth rate of -3.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 768.43M | 274.87% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | 701.04M | -26.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |